- Home
- BOLD vs FSEA Comparison
BOLD vs FSEA Comparison
Compare BOLD & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLD
- FSEA
- Stock Information
- Founded
- BOLD 2018
- FSEA 1890
- Country
- BOLD United States
- FSEA United States
- Employees
- BOLD N/A
- FSEA N/A
- Industry
- BOLD
- FSEA Savings Institutions
- Sector
- BOLD
- FSEA Finance
- Exchange
- BOLD Nasdaq
- FSEA Nasdaq
- Market Cap
- BOLD 49.5M
- FSEA 47.0M
- IPO Year
- BOLD 2024
- FSEA N/A
- Fundamental
- Price
- BOLD $1.96
- FSEA $10.82
- Analyst Decision
- BOLD Buy
- FSEA
- Analyst Count
- BOLD 3
- FSEA 0
- Target Price
- BOLD $22.50
- FSEA N/A
- AVG Volume (30 Days)
- BOLD 50.0K
- FSEA 12.1K
- Earning Date
- BOLD 04-03-2025
- FSEA 03-28-2025
- Dividend Yield
- BOLD N/A
- FSEA N/A
- EPS Growth
- BOLD N/A
- FSEA N/A
- EPS
- BOLD N/A
- FSEA N/A
- Revenue
- BOLD N/A
- FSEA $11,390,000.00
- Revenue This Year
- BOLD N/A
- FSEA N/A
- Revenue Next Year
- BOLD N/A
- FSEA N/A
- P/E Ratio
- BOLD N/A
- FSEA N/A
- Revenue Growth
- BOLD N/A
- FSEA N/A
- 52 Week Low
- BOLD $1.95
- FSEA $8.05
- 52 Week High
- BOLD $15.24
- FSEA $11.30
- Technical
- Relative Strength Index (RSI)
- BOLD N/A
- FSEA 67.92
- Support Level
- BOLD N/A
- FSEA $10.31
- Resistance Level
- BOLD N/A
- FSEA $10.97
- Average True Range (ATR)
- BOLD 0.00
- FSEA 0.24
- MACD
- BOLD 0.00
- FSEA 0.04
- Stochastic Oscillator
- BOLD 0.00
- FSEA 59.82
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.